el-Kassar N, Hetet G, Brière J, Grandchamp B
INSERM U409, Faculté de Médecine Xavier Bichat, Paris, France.
Blood. 1997 Jan 1;89(1):128-34.
Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by a sustained elevation of the platelet count in the absence of other causes of thrombocytosis. ET is difficult to diagnose, and the demonstration of clonal hematopoiesis may be of value. However, clonality analysis of hematopoietic cells based on the study of the X-chromosome inactivation pattern is complicated by the observation that some normal females present skewed lyonization. Moreover, DNA methylation of X-linked genes in hematopoietic cells may differ from that in other tissues. Appropriate controls for skewed lyonization are therefore critical for the study of clonality. We developed two techniques based on X-chromosome inactivation and polymerase chain reaction (PCR) analysis of polymorphisms, to study clonality in ET patients. Reverse transcriptase-PCR analysis of IDS, P55, and G6PD mRNAs was used to examine the different hematopoietic cell lineages including platelets in patients heterozygous for these polymorphisms and analysis of the HUMARA gene methylation pattern permitted us to study clonality in all nucleated cell fractions of the other patients. Using both types of assay and T lymphocytes as a control tissue for lyonization, clonal hematopoiesis was demonstrated in 28 patients. In 14 patients, the granulocytes were polyclonal; among these patients, platelets were monoclonal in 3 cases, polyclonal in 7 cases, and in the remaining 4 cases this fraction could not be studied because the patients were homozygotes for all RNA markers. No conclusion about clonality could be drawn in 6 cases. Polyclonal hematopoiesis was found in all the cases of reactive thrombocytosis. These findings confirm the high frequency of monoclonal hematopoiesis in ET, the utility of studying platelets, and the possibility of using T lymphocytes as a control tissues for X-chromosome inactivation patterns.
原发性血小板增多症(ET)是一种骨髓增殖性疾病,其特征是在没有其他导致血小板增多症的原因的情况下血小板计数持续升高。ET难以诊断,而克隆性造血的证明可能具有价值。然而,基于X染色体失活模式研究的造血细胞克隆性分析因观察到一些正常女性存在偏态莱昂化而变得复杂。此外,造血细胞中X连锁基因的DNA甲基化可能与其他组织不同。因此,适当控制偏态莱昂化对于克隆性研究至关重要。我们开发了两种基于X染色体失活和多态性聚合酶链反应(PCR)分析的技术,以研究ET患者的克隆性。对这些多态性杂合患者的IDS、P55和G6PD mRNA进行逆转录酶-PCR分析,以检查包括血小板在内的不同造血细胞谱系,对HUMARA基因甲基化模式的分析使我们能够研究其他患者所有有核细胞部分的克隆性。使用这两种检测方法并以T淋巴细胞作为莱昂化的对照组织,在28例患者中证实了克隆性造血。在14例患者中,粒细胞是多克隆的;在这些患者中,血小板在3例中是单克隆的,7例中是多克隆的,其余4例由于患者对所有RNA标记都是纯合子而无法研究该部分。6例患者无法得出关于克隆性的结论。在所有反应性血小板增多症病例中均发现多克隆造血。这些发现证实了ET中克隆性造血的高频率、研究血小板的实用性以及使用T淋巴细胞作为X染色体失活模式对照组织的可能性。